Back to Search Start Over

Use of intracavernosal alprostadil in erectile dysfunction.

Authors :
Gingell C
Source :
Hospital medicine (London, England : 1998) [Hosp Med] 1998 Oct; Vol. 59 (10), pp. 777.
Publication Year :
1998

Abstract

Alprostadil (prostaglandin E1) is the most widely used, licensed vasoactive agent for intracorporeal injection in the investigation and treatment of erectile dysfunction. It has a good side-effect profile and is effective in between 70 and 80% of patients.

Subjects

Subjects :
Humans
Male
Alprostadil therapeutic use
Erectile Dysfunction drug therapy
Vasodilator Agents therapeutic use

Details

Language :
English
ISSN :
1462-3935
Volume :
59
Issue :
10
Database :
MEDLINE
Journal :
Hospital medicine (London, England : 1998)
Publication Type :
Academic Journal
Accession number :
9850293

Tools

Authors Abstract Subjects Details